Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Sundry Debtors

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Sundry Debtors History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Sundry Debtors ₹273 Cr₹293 Cr₹222 Cr₹192 Cr₹205 Cr

What is the latest Sundry Debtors ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Sundry Debtors ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹273 Cr based on Mar2026 Consolidated results.
Year Sundry Debtors
Mar2026₹273 Cr
Mar2025₹293 Cr
Mar2024₹222 Cr
Mar2023₹192 Cr
Mar2022₹205 Cr

How is Sundry Debtors of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Sundry Debtors % Change
Mar2026 ₹273 Cr
-6.64
Mar2025 ₹293 Cr
31.75
Mar2024 ₹222 Cr
15.43
Mar2023 ₹192 Cr
-6.27
Mar2022 ₹205 Cr -

Compare Sundry Debtors of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹45,628.7 Cr -1.2% 5% 5.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,688.0 Cr -1.4% 6.3% 7.8% Stock Analytics
DIVIS LABORATORIES ₹295,080.0 Cr -1.8% 20.6% 70.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,677.0 Cr -1.9% 2.4% 22.7% Stock Analytics
DR REDDYS LABORATORIES ₹115,852.0 Cr 0.8% 12.6% 12.3% Stock Analytics
CIPLA ₹111,731.0 Cr -2.4% 4.4% -8.3% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-1.2%

5%

5.7%

SENSEX

1.8%

11.1%

-1.6%


You may also like the below Video Courses